Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency Microneedling
Launched by AARHUS UNIVERSITY HOSPITAL · Jan 31, 2020
Trial Information
Current as of April 30, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years of age
- • Acne scars in the facial area (predominantly rolling scars)
- • Comparable atrophic acne scars on each side of the face
- • Fitzpatrick skintype I-III
- Exclusion Criteria:
- • Pregnant or nursing women
- • Treatment with isotretinoin within the last 6 months
- • Current treatment with NSAID and prednisolone
- • Known tendencies to produce hypertrophic scars or keloids
- • Infection in the treatment area
- • Considered unable to follow the study protocol, e.g. alcohol dependence syndrome
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Copenhagen Nv, Denmark
Patients applied
Trial Officials
June Svendsen, Nurse
Study Director
Bispebjerg Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials